| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.004 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.004 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.004 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.005 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.005 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.1 | 0.005 |